Vadadustat in Patients with Anemia and Non–Dialysis-Dependent CKD

Guardat en:

Dades bibliogràfiques
Publicat a:	The New England Journal of Medicine vol. 384, no. 17 (Apr 29, 2021), p. 1589
Autor principal:	Pergola, Pablo E
Altres autors:	Farag Youssef MK, Agarwal Rajiv, Arnold, Susan, Bako Gabriel, Block, Geoffrey A, Burke, Steven, Castillo, Fausto P, Jardine, Alan G, Khawaja Zeeshan, Koury, Mark J, Lewis, Eldrin F, Lin, Tim, Luo Wenli, Maroni, Bradley J, Matsushita Kunihiro, McCullough, Peter A, Parfrey, Patrick S, Roy-Chaudhury, Prabir, Sarnak, Mark J, Sharma, Amit, Spinowitz Bruce, Tseng, Carol, Tumlin, James, Vargo, Dennis L, Walters, Kimberly A, Winkelmayer, Wolfgang C, Wittes Janet, Eckardt Kai-Uwe
Publicat:	Massachusetts Medical Society
Matèries:	Akebia Therapeutics Inc United States > US Hemodialysis Clinical trials Hypoxia-inducible factors Hemoglobin Cerebral infarction Collaboration Kidney diseases Heart failure Hypoxia Myocardial infarction Confidence intervals Erythropoietin Thromboembolism Drug dosages Erythropoiesis Patients Hydroxylase Anemia Heart attacks Prolyl hydroxylase Design Safety Congestive heart failure Dialysis
Accés en línia:	Citation/Abstract Full Text Full Text - PDF
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Sigues el primer a deixar un comentari!